UBIX THERAPEUTICS
Ubix Therapeutics is a research and development company that develops anti-cancer drugs.
UBIX THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical
Founded:
2018-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.ubixtrx.com
Total Employee:
1+
Status:
Active
Contact:
+82 2 6335 2475
Email Addresses:
[email protected]
Total Funding:
19 B KRW
Technology used in webpage:
Euro CrUX Top 50m CrUX Dataset Pound Sterling Japanese Yen
Similar Organizations
Polymed Biopharmaceuticals
Polymed Biopharmaceuticals is a drug research and development company.
ProAbTech
ProAbTech is a research and development company that develops conjugated biological drugs.
Pyxis Diagnostics
Pyxis Diagnostics is a biotechnology company that develops cancer diagnostics platforms.
RIBOMIC
R&D medicine based on their own platform for developing medicine
Investors List
Dayli Partners
Dayli Partners investment in Series B - Ubix Therapeutics
UTC Investment Co.
UTC Investment Co. investment in Series B - Ubix Therapeutics
Premier Partners
Premier Partners investment in Series B - Ubix Therapeutics
Korea Development Bank
Korea Development Bank investment in Series B - Ubix Therapeutics
Atinum Partners
Atinum Partners investment in Series B - Ubix Therapeutics
Partners Investment
Partners Investment investment in Series B - Ubix Therapeutics
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series A - Ubix Therapeutics
Premier Partners
Premier Partners investment in Series A - Ubix Therapeutics
Official Site Inspections
http://www.ubixtrx.com Semrush global rank: 5.52 M Semrush visits lastest month: 1.32 K
- Host name: 211.37.149.157
- IP address: 211.37.149.157
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Ubix Therapeutics"
Ubix Therapeutics - Crunchbase Company Profile & Funding
Organization. Ubix Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone โฆSee details»
(์ฃผ)Ubix Therapeutics
We are driven to utilize research and technology to innovate therapeutics and to help livesSee details»
(์ฃผ)Ubix Therapeutics - ubixtrx.com
HS Hong is the director of Chemistry, Manufacturing, and Controls at Ubix Therapeutics. Ms. Hong holds over 21 years of broadly diversified experience in pharmaceutical industry, having โฆSee details»
Ubix Therapeutics - LinkedIn
Saving lives by driving innovations in targeted protein degradation (TPD) therapeutics. Ubix Therapeutics is a preclinical-stage biotechnology company with full capacity for TPD โฆSee details»
Ubix Therapeutics Co. Ltd. - Drug pipelines, Patents ... - Patsnap
Explore Ubix Therapeutics Co. Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 6 news, and 2 literature, Disease Domain:Neoplasms, Immune System Diseases, โฆSee details»
Ubix Therapeutics - Overview, News & Similar companies
Mar 23, 2020 Debiopharm And Ubix Therapeutics Launch Research To Develop A New Anti-Cancer Modality - Antibody Degraducer® Conjugates LAUSANNE, Switzerland and SEOUL, โฆSee details»
(์ฃผ)Ubix Therapeutics - en.ubixtrx.com
05836) #1401, 7, Beobwon-ro 11-gil, Songpa-gu, Seoul, Republic of Korea Tel +82.2.6335.2475 Fax +82.2.6334.2475 [email protected]See details»
(์ฃผ)Ubix Therapeutics - ubixtrx.com
Ubix Therapeutics develops novel anti-cancer drugs based on Degraducer® platform technology. Degraducer® is a powerful, next-generation inhibitor technology that enables targeting of โฆSee details»
(์ฃผ)Ubix Therapeutics
(05836) ์์ธํน๋ณ์ ์กํ๊ตฌ ๋ฒ์๋ก11๊ธธ 7, ๋ฌธ์ ํ๋์ง์์ฐ์ ์ผํฐ C๋ 1401ํธ Tel 02-6335-2475 Fax 02-6334-2475 [email protected] โ Ubix TherapeuticsSee details»
UBIX THERAPEUTICS, SK BIOPHARMACEUTICALS ENTER INTO โฆ
Apr 14, 2022 For more information, visit Ubix Therapeuticsโ website at www.ubixtrx.com. About SK Biopharmaceuticals. SK Biopharmaceuticals and its U.S. subsidiary SK life science are โฆSee details»
UBX-103 - Drug Targets, Indications, Patents - Synapse - Patsnap
SEOUL, South Korea I January 02, 2024 I Ubix Therapeutics, Inc., a biotechnology company developing innovative oncology therapeutics based on targeted protein degradation (TPD), โฆSee details»
Ubix Therapeutics Receives US FDA Clearance to Proceed with
Seoul, South Korea, Jan. 02, 2024 -- Ubix Therapeutics, Inc., a biotechnology company developing innovative oncology therapeutics based on targeted protein degradation (TPD), โฆSee details»
Debiopharm and Ubix Therapeutics Launch Research to Develop a โฆ
Jun 16, 2021 LAUSANNE, Switzerland and SEOUL, South Korea, June 16, 2021 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company โฆSee details»
UBIX THERAPEUTICS KICK OFF AN IND-ENABLING STUDIS OF โฆ
Jul 19, 2021 Seoul, Republic of Korea โ July 20 th, 2021 โ South Korea-based biotech company, Ubix Therapeutics (en.ubixtrx.com), announced the current status of their lead โฆSee details»
(์ฃผ)Ubix Therapeutics - ubixtrx.com
Seoul, Republic of Korea โ July 20th, 2021 โ South Korea-based biotech company, Ubix Therapeutics (www.ubixtrx.com), announced the current status of their lead program, UBX โฆSee details»
UBIX THERAPEUTICS KICK OFF AN IND-ENABLING STUDIS OF
Jul 20, 2021 Seoul, Republic of Korea โ July 20th, 2021 โ South Korea-based biotech company, Ubix Therapeutics (en.ubixtrx.com), announced the current status of their lead program, UBX โฆSee details»
Ubix โ a cancer research based on Multilinkโข Degraducer®
Jun 16, 2021 Lausanne, Switzerland, Seoul, Republic of Korea โ June 16th, 2021 โ Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix โฆSee details»
(์ฃผ)Ubix Therapeutics - en.ubixtrx.com
In the case that structural information of target proteins is known, we have the potential to utilize in silico screening for 1) discovery of new binders, 2) acquisition of background information for โฆSee details»
(์ฃผ)Ubix Therapeutics - ubixtrx.com
For more information, visit Ubix Therapeuticsโ website at www.ubixtrx.com. About SK Biopharmaceuticals SK Biopharmaceuticals and its U.S. subsidiary SK life science are global โฆSee details»
(์ฃผ)Ubix Therapeutics - ubixtrx.com
We are conducting novel E3 ligase research on new mechanisms as well as binders of previously known E3 ligase such as CRBN, VHL, and IAP, and are carrying out pharmaceutical research โฆSee details»